- Home
- SBFM vs GLMD Comparison
SBFM vs GLMD Comparison
Compare SBFM & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- GLMD
- Stock Information
- Founded
- SBFM 2006
- GLMD 2000
- Country
- SBFM United States
- GLMD Israel
- Employees
- SBFM N/A
- GLMD N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- GLMD Health Care
- Exchange
- SBFM Nasdaq
- GLMD Nasdaq
- Market Cap
- SBFM 6.6M
- GLMD 7.5M
- IPO Year
- SBFM N/A
- GLMD 2014
- Fundamental
- Price
- SBFM $1.39
- GLMD $1.37
- Analyst Decision
- SBFM Strong Buy
- GLMD Hold
- Analyst Count
- SBFM 1
- GLMD 1
- Target Price
- SBFM $15.00
- GLMD N/A
- AVG Volume (30 Days)
- SBFM 47.2K
- GLMD 212.7K
- Earning Date
- SBFM 11-04-2025
- GLMD 08-28-2025
- Dividend Yield
- SBFM N/A
- GLMD N/A
- EPS Growth
- SBFM N/A
- GLMD N/A
- EPS
- SBFM N/A
- GLMD N/A
- Revenue
- SBFM $36,341,741.00
- GLMD N/A
- Revenue This Year
- SBFM $32.20
- GLMD N/A
- Revenue Next Year
- SBFM $32.74
- GLMD N/A
- P/E Ratio
- SBFM N/A
- GLMD N/A
- Revenue Growth
- SBFM 19.22
- GLMD N/A
- 52 Week Low
- SBFM $1.17
- GLMD $1.15
- 52 Week High
- SBFM $3.90
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- SBFM 44.01
- GLMD 43.24
- Support Level
- SBFM $1.35
- GLMD $1.33
- Resistance Level
- SBFM $1.45
- GLMD $1.63
- Average True Range (ATR)
- SBFM 0.07
- GLMD 0.11
- MACD
- SBFM -0.00
- GLMD 0.01
- Stochastic Oscillator
- SBFM 27.78
- GLMD 33.31
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.